|
||||||||
 |
 Media partners and press |
|
||||
 |
 |
||||
| Drug Discovery Today. | Genetic Engineering & Biotechnology News. | ||||
| Since its launch in 1996, Drug Discovery Today has been at the cutting edge of the science underpinning drug discovery and development. We deliver highly current reviews to our readers, not only addressing the rapid scientific developments in drug discovery associated technologies, but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed. Find out more » |
Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publishing brand around the globe sinceits launch in 1981. What began as a print publication has now expanded to leverage onlinemedia including web-exclusive news and features, webinars, videos, podcasts, and newsletters. GEN's therapeutic and technology coverage includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics,and to bioprocessing and commercialisation. Find out more » |
||||
 |
|||||
| Frost & Sullivan. | |||||
The Healthcare & Life Sciences IT Growth Par tnership Ser vices program combines our range of services, global perspective, and comprehensive market coverage to provide the tools that empower our clients to achieve their growth objectives. Through this program clients receive a continuous flow of market, technical, and econometric information , along with interactive applications ( our TEAM methodology) focused specifically on growth. A sample list of our market coverage includes Medical Care Providers, Managed Care Ser vices, Consumer-based Healthcare, Clinical Solutions, Business Solutions, and Healthcare Outsourcing. Find out more » |
|||||
 |
|
|
